Improvement in Atopic Dermatitis Signs and Symptoms With Once-Daily and Proactive Twice-Weekly Roflumilast Cream 0.15% or 0.05%: Results From the 52-Week Phase 3 INTEGUMENT-OLE Trial in Patients Aged ≥2 Years

Journal of Allergy and Clinical Immunology 2026

View at publisher
Authors: Mark Boguniewicz, Chih Ho Hong, Lawrence Eichenfield, Alexandra Golant, Adelaide Ann Hebert, Amy S. Paller, April Armstrong, Lisa Stein Gold, David A. Krupa, Patrick Burnett, Diane T. Hanna, Brett Stephenson
DOI: 10.1016/j.jaci.2025.12.018
Cited by: 0

Fields of Study & Subjects

Dermatology and Skin Diseases Asthma and respiratory diseases Contact Dermatitis and Allergies

Publication details

Journal / source
Journal of Allergy and Clinical Immunology
Volume
157
Issue
2
Pages
AB5–AB5
Publication date
1 February 2026
Language
EN